3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Polycystic Ovary Syndrome
4
Prostatic Neoplasms
2
Heart Failure
2
Cardiotoxicity
2
Solid Tumors
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Obesity
1
Lung Neoplasms
1
Inflammation
1
Hyperinsulinism
1
Hyperglycemia
1
Hereditary Sensory and Autonomic Neuropathies
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Adenocarcinoma of Lung
1
Interventions
Exercise
5
Vitamin D
3
Resistance Training
3
Omeprazole
3
Etanercept
3
Dexmedetomidine
3
Ascorbic Acid
3
salicylsalicylic acid
2
palbociclib
2
epigallocatechin gallate
2
XENP 1595
2
Tea
2
Tablets
2
Sufentanil
2
Probiotics
2
Nutrition Assessment
2
Morphine
2
Metformin
2
Ketorolac
2
Infliximab
2
Ibuprofen
2
Fish Oils
2
Endurance Training
2
Colchicine
2
Aspirin
2
soybean oil, phospholipid emulsion
1
montelukast
1
microcrystalline cellulose
1
ginger extract
1
falcarinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Inflammation
×
dapagliflozin
×
Clear all
NCT07245069
2025-11-24
Alpaca
University Medical Centre Ljubljana
Phase 2
Recruiting
100 enrolled